Back to Search
Start Over
O-3 Additional data from the KEYNOTE-859 study of pembrolizumab plus chemotherapy versus placebo plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer.
- Source :
-
Annals of Oncology . 2023 Supplement 1, Vol. 34, pS181-S181. 1p. - Publication Year :
- 2023
- Subjects :
- *ESOPHAGOGASTRIC junction
*CANCER chemotherapy
*PEMBROLIZUMAB
*PLACEBOS
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 34
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 164583596
- Full Text :
- https://doi.org/10.1016/j.annonc.2023.04.018